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Editorial comment 
Active sarcoidosis is well known to be an aetiologic 
factor in cases with recurrent laryngeal nerve paraly- 
sis. However, calcified mediastinal glands are not a 
common or well known cause of recurrent laryngeal 
nerve paralysis. 
It is normally accepted that about one-quarter of 
all recurrent nerve paralysis is ‘idiopathic’. The pres- 
ence of calcified mediastinal glands and the recurrent 
nerve paralysis may be coincidental. 
R. DAHL 
Editor 
Dear Editor 
Nocturnal hypoxaemia in cystic fibrosis 
We read with interest the paper by Smith et al. (1) 
on nocturnal hypoxaemia in cystic fibrosis. They 
examined a group of 35 adult CF patients and found 
that nocturnal hypoxaemia, as determined by a satu- 
ration ~90% for at least 10% of the recording, did 
not occur unless the awake saturation was less than 
93%. Nocturnal desaturation in children (2), and 
nocturnal hypoxaemia in adults (3,4), have been 
demonstrated with awake saturation as high as 95%. 
Adherence to a particular awake saturation may miss 
a minority of patients with significant nocturnal 
hypoxaemia, so this cannot be used as a reliable 
indicator. 
The authors suggest that extrapolating from data 
obtained at the conclusion of a period of hospital 
treatment to the ‘stable phase’ may result in over- 
diagnosis of nocturnal hypoxaemia, as some 
patients might continue to improve after discharge. 
We have recorded overnight saturation in 20 adult 
CF patients with nocturnal hypoxaemia at dis- 
charge from hospital after treatment of pulmonary 
exacerbation, and at home 10 days later. Mean 
nocturnal saturation was lower (P=O.O5) at home 
than at the time of hospital discharge. Awake satu- 
ration recorded at discharge is therefore likely to 
underestimate rather than overestimate nocturnal 
hypoxaemia following discharge. 
M. N. POND, M. B. ALLEN AND S. P. CONWAY 
Adult Cystic Fibrosis Unit 
Seacroft Hospital 
Leeds, U.K. 
24 November 1994 
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Reply to Dr Pond et al. 
We thank Dr Pond and colleagues for their interest 
in our work and their helpful comments. Although 
in our own patient group, significant nocturnal 
hypoxaemia was seen only in patients with an awake 
SaO2 of 93% or less, we accept that others have 
described similarly significant nocturnal hypoxaemia 
in small numbers of patients with awake SaO2 values 
of up to 95%. We do not agree, however, that 
this makes awake SaO2 unreliable as a predictor 
of significant nocturnal hypoxaemia; raising the 
threshold value merely makes the prediction less 
specific (but more sensitive). 
Dr Pond’s finding that mean nocturnal saturation 
was lower at home 10 days after hospital discharge 
than in hospital at the time of discharge in a group 
of 20 CF adults is interesting. Our own studies of 
22 patients in the home environment revealed a 
higher threshold of awake SaO2 (>94%) that 
excluded significant nocturnal hypoxaemia than was 
seen in hospital. It seems likely that an increased 
proportion of time spent in REM sleep at home 
relative to hospital may explain some of these 
differences. 
D. L. SMITH 
Department of Respiratory Medicine 
Glenfield Hospital 
Leicester, U.K. 
25 April 1995 
